Official: Remdesivir's clinical trial results out on April 27

The clinical trials of antiviral drug remdesivir have officially started at a number of hospitals in central China's Wuhan City, the epicenter of the COVID-19, and the results are expected on April 27, said He Zhimin, vice director of the State Intellectual Property Office, at a media briefing on Tuesday.

Remdesivir has not been approved for marketing in any country as it is still in the clinical stage, said He.

The registration for clinical trials of the antiviral drug was approved early February.